Pull to refresh
Logo
Scientists identify the stem cell that builds tendons and ligaments

Scientists identify the stem cell that builds tendons and ligaments

New Capabilities

Discovery links the cell to spinal stenosis and points to a possible drug treatment

4 days ago: Weill Cornell announces discovery and spinal stenosis implications

Overview

Updated 4 days ago

Researchers have isolated the stem cell that builds tendons and ligaments in both mice and humans, for the first time. The cell, identified by a specific set of surface markers, self-renews and produces every other cell type in these tissues.

The discovery has a direct clinical target. When these stem cells become hyperactive in the lower spine, they enlarge the ligamentum flavum and narrow the spinal canal, causing lumbar spinal stenosis. That condition affects an estimated 103 million people worldwide and has no drug treatment.

The team showed that calcium signaling drives the overgrowth, and blocking it in mice stopped the pathology. That points to calcium channel blockers, already used for high blood pressure, as a possible therapy.

Why it matters

Millions with spinal stenosis have no drug treatment; this discovery names the cell driving the disease and a drug class that may stop it.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

103 million
People affected by lumbar spinal stenosis worldwide
Estimated global prevalence of the condition the tendon/ligament stem cell drives.
11%
Older adults in the US with lumbar spinal stenosis
Prevalence of the condition among older adults in the United States.
CD73+CD140α−
Stem cell surface markers
The marker set that defines the tendon/ligament stem cell in mice and humans.

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

Sign up to generate historical perspectives on this story.

People Involved

Organizations Involved

Timeline

2 events Latest: 4 days ago
  1. Weill Cornell announces discovery and spinal stenosis implications

    Latest Announcement

    Weill Cornell Medicine and Hospital for Special Surgery announced the finding, highlighting calcium channel blockers as a potential treatment for lumbar spinal stenosis.

  2. Cell publishes identification of the tendon/ligament stem cell

    Publication

    The journal Cell published the study identifying the TLSC as Lin−Thy1.2−Sca-1−CD73+CD140α− cells in mice and humans.

Scenarios

1

Calcium channel blockers move to clinical trials for spinal stenosis

Possible Resolves by Sep 8, 2027

Discussed by: Weill Cornell researchers and medical press coverage

The team showed that blocking calcium signaling stopped cell overgrowth in a mouse model of lumbar spinal stenosis. If the finding translates, calcium channel blockers already approved for hypertension could be tested in patients. Clinical studies are needed to explore this direction.

2

TLSC markers become the standard for tendon research

Likely Resolves by Sep 8, 2027

Discussed by: Tendon biology community

The marker set (Lin−Thy1.2−Sca-1−CD73+CD140α−) could become the standard way to identify tendon and ligament stem cells, accelerating research into tendon repair and regeneration. Independent labs would need to adopt and validate the markers.

3

Stem cell therapy for tendon injuries advances to trials

Possible Resolves by Sep 8, 2028

Discussed by: Regenerative medicine researchers

The identification of a universal TLSC opens the door to cell-based therapies for poorly healing tendon and ligament injuries, including rotator cuff tears and Achilles tendon injuries. If the stem cells can be expanded and transplanted, they might improve healing outcomes.

Historical Context

2 moments from history that rhyme with this story — and how they unfolded.

1961

Hematopoietic stem cell discovery (1961)

James Till and Ernest McCulloch injected bone marrow cells into irradiated mice and observed spleen colonies, proving a single cell could produce all blood cell types. This was the first formal demonstration of a tissue stem cell.

Then

Established the functional assay framework for identifying stem cells in any tissue.

Now

Led to bone marrow transplantation and the entire field of stem cell biology.

Why this matters now

The TLSC identification uses the same functional logic, self-renewal and differentiation assays, that Till and McCulloch pioneered for blood stem cells.

1990s

Mesenchymal stem cell characterization (1990s)

Arnold Caplan and colleagues characterized multipotent stromal cells from bone marrow that could differentiate into bone, cartilage, and fat. These cells were proposed as the stem cells for connective tissues.

Then

Sparked a wave of research into connective tissue regeneration and cell therapy.

Now

MSC markers proved imprecise, and the field struggled to define a true connective tissue stem cell.

Why this matters now

The new TLSC provides a precise marker set for a true tendon/ligament stem cell, resolving a gap left by the broader MSC concept.

Sources

(7)